Navigation Links
IRSF lauds record turn-out for annual Rett Syndrome Symposium

(Cincinnati, OH) IRSF's 11th Annual Rett syndrome Symposium held June 27, 28, and 29 in Leesburg, Virginia brought together leading scientists and researchers in the fields of neurobiology from around the globe who are attempting to demystify Rett syndrome. About 25 presenters led a day and a half of in-depth sessions attended by nearly 150 investigators and scientists, volunteers, families affected by the disease and IRSF staff.

The 2010 IRSF Symposium was Chaired by David M. Katz, PhD of Case Western Reserve University, School of Medicine and Co-Chaired by Yi Eve Sun, PhD of the University of California, Los Angeles. It kicked-off with a Keynote Address given by, distinguished Rett syndrome investigator, Huda Y. Zoghbi, MD of Baylor College of Medicine. The meeting structure largely built on groundwork laid in previous years. For the second year in a row, the closing session on treatment strategies attracted a full-house demonstrating this group's strong ongoing interest in the application of knowledge to the plight of the patient.

Most notably, new relationships and collaborations were forged as researchers had a chance to examine and contribute their knowledge to the work of the other members of the group. For the first time, this year's Symposium featured a session on Autism Spectrum Disorders (ASDs), a subject which attracted a lot of interest and discussion among the participants.

Chief Scientific Officer, Dr. Antony Horton said, "The record turn-out highlights our leadership in bringing premiere investigators in the Rett field together with accomplished scientists who are working towards developing tomorrow's medicines for Rett syndrome and related diseases."

Poster Session Prizes

About 45 attendees submitted poster abstracts describing the results of their research. Judges reviewed the posters and selected three prize winners:

First Prize, named after Dr. Zoghbi, went to Bruno Blanchi, PhD of The University of California, Los Angeles. The poster was titled Modeling Rett Syndrome using human ES cell-derived neurons. For his efforts, Dr. Blanchi received a QuantiFire XI microscope camera.

The prize for best poster presented by a post-doctoral fellow was awarded to Severine Durand, PhD of Children's Hospital, Boston for her poster titled Role of MeCP2 in development of cortical circuits. Dr. Durand received a Microfire microscope camera for her laboratory

Similarly, the prize for best poster presented by a graduate student was presented to Kristin Kernohan, PhD candidate of The University of Western Ontario for her poster titled ATRX partners with cohesion and MeCP2 and contributes to developmental silencing of imprinted genes in the brain. Ms. Kernohan also received a Microfire microscope camera for the laboratory of her mentor, Dr. Natalie Brub.

The prizes were presented by Mr. Christopher Kolendrianos on behalf of Optronics, a division of Karl Storz Imaging. Mr. Kolendrianos is the father of Sorel, age four, who was diagnosed with Rett syndrome at 18 months.


Contact: Jim Keller
International Rett Syndrome Foundation

Related biology news :

1. BCIU Applauds Presidential Summit on Entrepreneurship, Sees Efforts Generating Goodwill, Partnerships and Jobs
2. SeaWeb applauds US decision to support bluefin tuna trade protection
3. AACR applauds nomination of Francis S. Collins, M.D., Ph.D., to be the new NIH director
4. Taxpayer Alliance applauds bill to broaden access to federal research results
5. NJIT applauds students for studies on brain injury, glaucoma and more
6. AAAE Applauds Expansion of Registered Traveler Program to Nations Capital
7. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
8. ScriptRx and DigitalPersona Team Up to Secure Emergency Room and Urgent Care Electronic Medical Records
9. Bats echolocation recorded for human exploit
10. Call Recording Enhances Performance at UK Gloucestershire Police
11. Innovalight Establishes New Record With Silicon Ink Solar Cells
Post Your Comments:
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016  The Prostate Cancer Foundation (PCF) is pleased to announce ... cures for prostate cancer. Members of the Class of 2016 were selected from ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... ... Supplyframe, the Industry Network for electronics hardware design and ... in Pasadena, Calif., the Design Lab’s mission is to bring together inventors and ... brought to market. , The Design Lab is Supplyframe’s physical representation of one ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... the trading session at 4,833.32, down 0.22%; the Dow Jones ... the S&P 500 closed at 2,085.45, down 0.17%. has ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ... BIND Therapeutics Inc. (NASDAQ: BIND ). Learn more ...
Breaking Biology Technology: